cetylpyridinium chloride anhydrous has been researched along with Behcet Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atalay, A; Atalay, EO; Bağci, H; Cobankara, V; Sanli-Erdoğan, B; Tatlipinar, S; Yildirim, C; Yildiz-Demirtepe, S | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Behcet Syndrome
| Article | Year |
|---|---|
HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.
Topics: Behcet Syndrome; beta 2-Microglobulin; Binding Sites; Female; Gene Expression Regulation; Health; HLA-B Antigens; HLA-B51 Antigen; Humans; Male; Monomeric GTP-Binding Proteins; Receptors, Antigen, T-Cell; RNA, Messenger; Turkey | 2008 |